Current Advances in Allosteric Modulation of Muscarinic Receptors
Open accessThe DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.
Abstract
Allosteric modulators are ligands that bind to a site on the receptor that is spatially separated from the orthosteric binding site for the endogenous neurotransmitter. Allosteric modulators modulate the binding affinity, potency, and efficacy of orthosteric ligands. Muscarinic acetylcholine receptors are prototypical allosterically-modulated G-protein-coupled receptors. They are a potential therapeutic target for the treatment of psychiatric, neurologic, and internal diseases like schizophrenia, Alzheimer’s disease, Huntington disease, type 2 diabetes, or chronic pulmonary obstruction. Here, we reviewed the progress made during the last decade in our understanding of their mechanisms of binding, allosteric modulation, and in vivo actions in order to understand the translational impact of studying this important class of pharmacological agents. We overviewed newly developed allosteric modulators of muscarinic receptors as well as new spin-off ideas like bitopic ligands combining allosteric and orthosteric moieties and photo-switchable ligands based on bitopic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 An orthosteric ligand L binds to the receptor R with equilibrium dissociation constant KD, and an allosteric modulator A binds to the receptor R with an equilibrium dissociation constant KA. The orthosteric ligand L and the allosteric modulator A can bind concurrently to the receptor R to form a ternary complex LRA. Binding of one ligand to the receptor changes the equilibrium dissociation constant of the other ligand by a factor of cooperativity α [15].](https://figures.cochat.ai/paper-figures/b8848fd3264b44ec85a45661d45fb5e7/current-advances-in-allosteric-modulation-of-muscarinic-receptors-figure-1.jpg)









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Allosteric modulators typically attach to regions distinct from the orthosteric site of receptors, inducing conformational changes to regulate the affinity and/or efficacy of orthosteric ligands, or to directly modulate receptor activity with positive, negative, or neutral effects.542–545”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [542]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825 · cited 2×
“The concept of allosterism was formally introduced into the field of enzymology by Monod et al.[13] and Koshland et al.”
BackgroundComparison of Experimental Binding Data and Theoretical Models in Proteins Containing Subunits*
Koshland, D. E., Némethy, G., & Filmer, D. (1966) · Biochemistry · doi:10.1021/bi00865a047 · Cited by 3,013
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,427 · cited 1×
“Five distinct subtypes of muscarinic acetylcholine receptors (M1-M5) have been identified in the human genome[1].”
BackgroundActivation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893 · cited 6×
“The availability of the M2 receptor crystal structure in an inactive [2], as well as active conformation [4] and advances in computer modeling, has allowed for the acceleration of structurebased design of chemically diverse allosteric modulators of this receptor [79].”
BackgroundInfluentialStructure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811 · cited 1×
“Interaction of orthosteric ligands with the allosteric domain between the o2 and o3 loops has been confirmed and studied in detail by computer modeling [3,58,59].”
BackgroundStructure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W. I., Okada, T., Kobilka, B. K., Haga, T., et al. (2012) · Nature · doi:10.1038/nature10753 · Cited by 792 · cited 2×
“The availability of the M2 receptor crystal structure in an inactive [2], as well as active conformation [4] and advances in computer modeling, has allowed for the acceleration of structure-based design of chemically diverse allosteric modulators of this receptor [79].”
BackgroundSignalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740 · cited 1×
“This preferential orientation of the signaling of a GPCR towards a subset of its signal transducers is termed signaling bias[45].”
BackgroundMash, D. C., Flynn, D. D., & Potter, L. T. (1985) · Science · doi:10.1126/science.3992249 · Cited by 698 · cited 2×
“Encouragingly, post-synaptic receptors are relatively intact in neurod g nerative diseases like Alzheimer’s disease or senil dementia of Lewy b y typ [21,22].”
BackgroundHow Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
Research works printed but not linked: 1
- Ballesteros, 1995, Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors, Methods Neurosci., 25, 366, 10.1016/s1043-9471(05)80049-7 · DOI · Paper page
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Paul, S. M., Yohn, S. E., Popiolek, M., Miller, A., & Felder, C. C. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21101083 · Cited by 165
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Dwomoh, L., Tejeda, G. S., & Tobin, A. B. (2022) · Neuronal Signaling · doi:10.1042/ns20210004 · Cited by 60
Shpakov, A. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076187 · Cited by 60
Yohn, S. E., Harvey, P. D., Brannan, S. K., & Horan, W. P. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1421554 · Cited by 40
“For instance, simulation of molecular dynamics have revealed cryptic allosteric binding pockets in the vicinity of the common allosteric binding site (28).”
Background
Metadata
- Authors
- Jakubik, J., & El-Fakahany, E. E.
- Affiliations
- Department of Neurochemistry, Institute of Physiology CAS, 142 20 Prague, Czech Republic
- Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-02-18
- Volume
- 10
- Issue
- 2
- Pages
- 325
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7072599
- OpenAlex
- W3000377840
- Cited by
- 48
- References
- 92
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 12 · 2023: 8 · 2022: 7 · 2021: 6 · 2020: 4
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Grantová Agentura České Republiky (19-05318S)
- Akademie věd České Republiky (RVO:67985823)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- muscarinic receptors, allosteric modulation, allosteric modulators, G protein-coupled receptors, bitopic ligands, orthosteric binding site, receptor binding mechanism, muscarinic agonists, antimuscarinic agents, schizophrenia, Alzheimer's disease, Huntington's disease, type 2 diabetes
- MeSH terms
- Allosteric Regulation, Animals, Binding Sites, Humans, Ligands, Receptors, Muscarinic, Muscarinic Agonists, Muscarinic Antagonists, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Advances in Allosteric Modulation of Muscarinic Receptors. https://app.cochat.ai/papers/10.3390/biom10020325
- The paper
- Jakubik, J., & El-Fakahany, E. E. (2020). Current Advances in Allosteric Modulation of Muscarinic Receptors. Biomolecules. https://doi.org/10.3390/biom10020325
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.